Extracorporeal Shockwave Therapy (ESWT) otherwise referred to as shockwave therapy, was first introduced into clinical practice in 1982 for the management of urologic conditions. The success of this technology for the treatment of urinary stones quickly made it a first-line, noninvasive, and effective method. Subsequently, ESWT was studied in orthopedics where it was identified that it could loosen the cement in total hip arthroplasty revisions. Further, animal studies conducted in the 1980s revealed that ESWT could augment the bone-cement interface, enhance osteogenic response and improve fracture healing. While shockwave therapy has been shown to be beneficial in fracture healing, most orthopedic research has focused on upper and lower extremity tendinopathies, fasciopathies, and soft tissue conditions.
Pneumatic Shockwave Therapy produces Radial shockwaves. They are called Soft Shockwaves and penetrate deep and effectively without focussing energy at a single point. This is the best and most effective technology used in pain management. Patients feel very comfortable during the treatment and pneumatic shockwaves have a much wider range of applications.
Indications:
- Upper and lower extremity tendinopathies
E.g. Tendo-Achillis Tendinitis, Supraspinatus tendinitis, Bicipital Tendinitis, Tennis Elbow, Golfer’s Elbow, De Quervain’s Tenosynovitis, etc.
- Greater trochanteric pain syndrome
- Medial tibial stress syndrome
- Patellar tendinopathy
- Plantar fasciopathy.
- Adhesive capsulitis / Frozen Shoulder
- Non-union of long bone fracture
- Avascular necrosis of femoral head
- Osteoarthritis of the knee
- Arthritic Hand Pain
- Myofascial Triggers
- Trapezitis
- Calcific Tendinitis
- Plantar Fasciitis
- Lateral / Medial Epicondylitis
- IT Band Stiffness
- Gluteus Triggers
- Foot disorders etc.